Atlas Capital Advisors’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$96.1K Sell
1,472
-2,327
-61% -$170K 0.01% 540
2025
Q4
$306K Buy
+3,799
New +$305K 0.03% 340
2025
Q2
$809K Buy
8,867
+5,560
+168% +$497K 0.1% 176
2025
Q1
$303K Buy
3,307
+902
+38% +$78.7K 0.04% 333
2024
Q4
$205K Sell
2,405
-42
-2% -$3.69K 0.03% 384
2024
Q3
$214K Buy
2,447
+1,682
+220% +$142K 0.03% 363
2024
Q2
$60.4K Sell
765
-1,875
-71% -$154K 0.01% 562
2024
Q1
$239K Buy
2,640
+160
+6% +$14.6K 0.04% 339
2023
Q4
$218K Sell
2,480
-473
-16% -$39.4K 0.03% 354
2023
Q3
$249K Sell
2,953
-118
-4% -$10.7K 0.04% 309
2023
Q2
$304K Hold
3,071
0.05% 289
2023
Q1
$295K Hold
3,071
0.05% 288
2022
Q4
$279K Sell
3,071
-91
-3% -$7.74K 0.05% 278
2022
Q3
$251K Buy
3,162
+863
+38% +$73.1K 0.05% 304
2022
Q2
$192K Buy
+2,299
New +$190K 0.03% 376

Other funds holding DOX

Atlas Capital Advisors's DOX Position: Q1 2026 in Review

Atlas Capital Advisors reduced its Amdocs (DOX) stake by 61% in Q1 2026, selling an estimated $170K and leaving 1,472 shares worth $96.1K. The position accounts for 0.01% of the portfolio, ranked #540.

Atlas Capital Advisors first reported a position in DOX in Q2 2022 and has held it in 15 quarters since. The position peaked at $809K in Q2 2025. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Atlas Capital Advisors held 1,472 shares of Amdocs worth $96.1K as of Q1 2026.
  • Atlas Capital Advisors sold 2,327 Amdocs shares in Q1 2026, an estimated $170K.
  • Amdocs made up 0.01% of Atlas Capital Advisors's portfolio in Q1 2026, its #540 holding.
  • Atlas Capital Advisors first reported a position in Amdocs in Q2 2022 and has held it in 15 quarters since.
  • Atlas Capital Advisors's Amdocs position peaked at $809K in Q2 2025.
  • 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.